VeriMomlipase est-il sûr pendant la grossesse ?
No harmonised CLP reproductive classifications or CIR/SCCS safety assessments identify lipase (CAS 9001-62-1) as a reproductive or teratogenic hazard; ECHA lists the substance as an enzyme registration but no H360/H361 harmonised classification is present. However, SCCS data (Vitamin A opinion) show that topical lipase can rapidly metabolise/alter retinyl palmitate and increase cutaneous bioavailability of co-applied retinoids, so the primary concern is indirect (increasing penetration of other active ingredients) rather than intrinsic reproductive toxicity. ([echa.europa.eu](https://echa.europa.eu/substance-information/-/substanceinfo/100.029.642?utm_source=openai))
Pregnancy-safe products containing lipase
Related ingredients
Frequently asked questions
- lipase est-il sûr pendant la grossesse ?
- No harmonised CLP reproductive classifications or CIR/SCCS safety assessments identify lipase (CAS 9001-62-1) as a reproductive or teratogenic hazard; ECHA lists the substance as an enzyme registration but no H360/H361 harmonised classification is present. However, SCCS data (Vitamin A opinion) show that topical lipase can rapidly metabolise/alter retinyl palmitate and increase cutaneous bioavailability of co-applied retinoids, so the primary concern is indirect (increasing penetration of other active ingredients) rather than intrinsic reproductive toxicity. ([echa.europa.eu](https://echa.europa.eu/substance-information/-/substanceinfo/100.029.642?utm_source=openai))
- lipase est-il sûr pendant l'allaitement ?
- No evidence that lipase itself causes reproductive or lactation-related toxicity or that it is a known human teratogen. Dermally applied enzyme preparations are large protein molecules with negligible systemic absorption in normal cosmetic use, so direct exposure to breastfed infants is unlikely; the main mechanism-based concern is again indirect — lipase can alter penetration/metabolism of co-formulated actives (e.g., retinoids) which are of concern in pregnancy/lactation. No data were found showing lipase partitions into breastmilk or exerts direct effects on lactation. ([echa.europa.eu](https://echa.europa.eu/substance-information/-/substanceinfo/100.029.642?utm_source=openai))
- lipase est-il sûr pour la peau de bébé ?
- There is no evidence that lipase is a reproductive toxicant for infants. For baby (0–3 yr) skin, absorption/exposure scoring is increased by +1 per your rules because infant skin has a less mature barrier and higher surface-area-to-weight — while lipase is a large enzyme with generally low dermal absorption, infant exposure is plausibly higher than adult. The same indirect-mechanism caveat applies: lipase can metabolise or increase penetration of co-applied actives (SCCS Vitamin A data). No infant-specific toxicity data were identified. ([cirs-group.com](https://www.cirs-group.com/files/bjaxyplqmqyo/content/2022/11/c2965g2xf4zk.pdf?utm_source=openai))
- Comment VeriMom évalue-t-il lipase ?
- VeriMom évalue lipase à 93/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à lipase pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à lipase basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.